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Down syndrome (DS) is the most common genetic cause of intellectual 
disability. Evidence suggests that live-birth prevalence of DS is high in 
South Africa: 1.33 - 1.8 per 1 000 live births in two urban areas,1,2 and 
2.1 per 1 000 in a rural area.3
Prenatal screening for DS was established in the 1970s using 
advanced maternal age (AMA) as a risk factor, and this remains the 
standard of care in the public health sector of South Africa. National 
policy provides for free amniocentesis to be offered to AMA women, 
whereas biochemical screening is not offered and access to fetal 
ultrasound is limited.
Cape Town’s public health services are among the best developed 
in South Africa. Although access to fetal ultrasound has increased in 
recent years, AMA remains a frequent indication for prenatal genetic 
counselling. The study focused on the Cape Town Metropole West 
health district (CT West) to obtain evidence regarding the effectiveness 
of age-based screening for the prevention of DS, and preliminary 
evidence regarding factors affecting utilisation of prenatal diagnosis. 
We assessed (i) laboratory trends in prenatal diagnostic testing over 
a 30-year period, (ii) trends in uptake of prenatal diagnostic testing 
among women receiving genetic counselling and (iii) the referral 
pathway from primary care to tertiary care.
Methods
Study population. Women attending state antenatal health care 
services in CT West, which comprises a large and diverse urban 
population, with a majority coloured population, and minorities of 
whites and blacks. The district has experienced rapid urbanisation and 
considerable demographic changes. In 2005, there were approximately 
34 000 deliveries in the district (Patel, unpublished data).
Study sites and services. The antenatal health service and 
cytogenetic laboratory service in CT West have been stable since the 
1970s. The health service includes several primary and secondary level 
facilities, and tertiary level fetal medicine and pregnancy counselling 
services at Groote Schuur Hospital (GSH). The University of Cape 
Town (UCT) Cytogenetic Laboratory (CL) has provided prenatal 
and postnatal diagnostic laboratory services to CT West throughout 
the period. Prenatal diagnostic testing is almost exclusively by 
amniocentesis, and indications have included increased risk of DS 
(most commonly AMA, but more recently also based on ultrasound 
markers (first trimester nuchal translucency thickness and second 
trimester soft markers) and fetal anomalies detected on ultrasound. 
The age cut-off for AMA counselling has varied over the years.
UCT CL database. The laboratory has maintained a database of 
samples received since the early 1970s. Initially this was a written 
record but all records were transferred to Microsoft Access in the 
mid-1990s, and a parallel written and computerised database was 
maintained. To improve data quality, the database was cleaned by 
cross-referencing blank or unclear computer data fields with the 
written records – the remaining missing data represented less than 5% 
of data points per category. Categories analysed were: type of sample 
received, maternal age, indication for testing, referring institution 
(as a proxy for the patient’s residential address) and the karyotype 
result obtained. Data from January 1976 to December 2005 were 
retrospectively analysed in 5-year periods to assess trends in prenatal 
and postnatal diagnosis of autosomal trisomies. The information 
did not permit us to link prenatal and postnatal diagnoses. Since the Corresponding author: M Urban (urban@sun.ac.za)
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Effectiveness of prenatal screening for Down syndrome on the 
basis of maternal age in Cape Town
M F Urban, C Stewart, T Ruppelt, L Geerts
Objective. The prenatal screening programme for Down syndrome 
(DS) in the South African public health sector remains primarily 
based on advanced maternal age (AMA). We assessed the changes 
over time and effectiveness of this screening programme within a 
Cape Town health district.
Methods. Retrospective analysis of the Groote Schuur Hospital 
Cytogenetic Laboratory and Pregnancy Counselling Clinic 
databases and audit of maternal delivery records at a primary 
health care facility.
Results. The number of amniocenteses performed for AMA in 
consecutive 5-year periods reduced progressively from 786 in 
1981 - 1985 to 360 in 2001 - 2005. Comparing prenatal with 
neonatal diagnoses of DS, the absolute number and the proportion 
diagnosed prenatally have remained relatively constant over time. 
The Pregnancy Counselling Database showed that, of 507 women 
receiving genetic counselling for AMA in 2008 - 2009, 158 (31.1%) 
accepted amniocentesis – uptake has reduced considerably since 
the early 1990s. The audit of women delivering at a primary care 
facility found that only 10 (16.4%) of 61 AMA women reached 
genetic counselling in tertiary care: reasons included late initiation 
of antenatal care and low referral rates from primary care.
Conclusion. Prenatal screening and diagnosis for DS based on AMA 
is working ineffectively in the Cape Town health district assessed, 
and this appears to be representative of a broader trend in South 
Africa. Inclusion of fetal ultrasound in the process of prenatal 
screening for DS should be explored as a way forward.
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laboratory handles all prenatal and postnatal tests for the CT West 
district, we restricted the analysis to samples emanating from this 
area to maximise comparability of prenatal and postnatal samples. 
Neonatal samples (from the first 28 days of postnatal life) were 
analysed separately from other postnatal samples, because prenatal 
and neonatal diagnoses are most likely to relate to the same cohort of 
pregnancies. We accepted that under-ascertainment in the neonatal 
period would probably lead to some overestimation of the proportion 
of DS cases diagnosed prenatally.
GSH Prenatal Counselling Clinic database. Since January 
2008, a Pregnancy Counselling database (Microsoft Access) has 
been maintained for clinical audit of genetic counselling sessions 
including: information on maternal age, gestational age, indication 
for counselling, ultrasound results, uptake and outcome of prenatal 
diagnostic testing. This was retrospectively analysed from January 
2008 to December 2009, to assess the uptake of prenatal diagnostic 
testing for different indications.
Primary care facility. To explore the referral process from 
primary care to the prenatal genetic counselling service, a single, 
well-functioning primary care facility in the CT Metro West district 
– the Hanover Park Maternity Obstetric Unit – was audited. This 
comprised a retrospective record review of consecutive antenatal 
records of AMA women who delivered at the facility between 
1 January 2009 and 30 June 2009.
Statistical analysis. Where relevant, univariate analysis was 
performed using the chi-square test.
Ethical considerations. The cytogenetic and pregnancy counselling 
databases are maintained for record-keeping and clinical audit. Their 
design and maintenance ensure patient confidentiality in accordance 
with UCT Research Ethics Committee recommendations. The audit 
of the primary care facility was approved by the UCT Research 
Ethics Committee and the relevant sub-district of the provincial 
Department of Health.
Results
In the study period, 5 943 amniotic fluid samples were tested in the 
UCT CL, of which 5 319 were from women referred from health care 
facilities in the now designated CT West. Fig. 1 shows the trend in 
the number of amniocentesis samples processed, together with their 
indication. The total number peaked in the early 1980s and then 
decreased, with a plateau beyond 1996. There has been a continuing 
reduction in amniocenteses for AMA despite a concurrent reduction 
in the cut-off age for offering AMA-based testing. The number of 
amniocenteses performed for AMA more than halved from a high of 
786 in 1981 - 1985, to a low of 360 in 2001 - 2005.
Fig. 2 shows the number of DS diagnoses made in the prenatal 
period, neonatal period, and all postnatal diagnoses. The total 
number of DS cases detected in the neonatal period, or at any age 
postnatally, has remained relatively constant except for the first 5-year 
period (probably representing a catch-up in karyotype testing in this 
period). Prenatal diagnoses have also remained relatively constant, 
but only a small proportion of DS cases were diagnosed prenatally in 
any time period. Using as a denominator the DS cases diagnosed by 
the end of the neonatal period (per 5-year interval), the proportion 
of the cases diagnosed prenatally varied from a minimum of 10.4% 
(12 of 115 cases) to a maximum of 13.5% (15 of 111 cases). In the 
most recent 5-year period, 13 (12.5%) of 104 cases were diagnosed 
prenatally – the indication for testing was AMA in 7 of these cases, 
and related to ultrasound findings in 6. Alternatively, using total DS 
diagnoses at any age as a denominator, the proportion of prenatal 
diagnoses varied from 6.6% (12 of 183) to 8.6% (16 of 187).
Uptake of amniocentesis by women receiving genetic counselling 
for AMA or for fetal anomalies is shown in Table I, and is presented 
alongside data from the same service for a 2-year period in 1992 - 
1994. During the intervening years, the cut-off age for referral to 
genetic counselling was reduced from 39 to 37 years. Comparing the 
two time periods, the uptake of amniocentesis for AMA more than 
halved, even if the analysis was restricted to women >39 years. In 
2008 - 2009, the uptake for the indication of AMA was significantly 
lower than that for fetal anomalies (p<0.0001, odds ratio (OR) 0.21 
(0.14 - 0.30)).
The primary care facility audit (Fig. 3) shows dropout at several 
steps on the referral pathway of women from primary care to prenatal 
diagnosis in tertiary care. Less than half of women presenting before 
20 weeks’ gestation received genetic counselling. The reasons for 
this are uncertain, but clinic midwives indicated that there was 
uncertainty about the age cut-off for referral. Although provincial 
referral guidelines recommend referral for amniocentesis at 16 - 20 
weeks for women >37 years old, some nurses still used 38 years as a 
cut-off (a previous guideline recommendation). The audit numbers 
 
 
 
 
Fig. 1. Uptake of amniocentesis by indication, and per 5-year period. 
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Fig. 2. Frequency of prenatal and postnatal diagnosis of DS per 5-year period. 
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Fig. 3. Flow diagram of AMA patients from primary health care through the 
referral process for genetic counselling.
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were insufficient to assess whether this significantly reduced genetic 
counselling in 37-year-olds. The midwives also thought that women 
preferred referral for ultrasound rather than for age-related reasons.
Discussion
The main findings of the study are that, in CT West, (i) only a small 
fraction of proven DS cases are diagnosed prenatally, (ii) utilisation of 
AMA counselling is low, and (iii) uptake of prenatal testing for AMA 
has reduced considerably over time.
The proportion of Down syndrome cases diagnosed prenatally 
has remained low and relatively constant over time, with an increasing 
proportion of these diagnoses based on ultrasound-detected fetal 
anomalies rather than AMA screening. The total number of postnatal 
DS diagnoses in CT West has also remained relatively constant 
despite rapid urbanisation and increasing numbers of births in the 
district. We speculate that this may be related to a reduction in the 
average age at which women have children.
Audit data obtained from laboratories providing cytogenetic 
services to the government sector indicates a nationwide low 
utilisation of prenatal diagnostic testing for AMA. In 2008, these 
laboratories received 529 amniocenteses for AMA (unpublished 
data for 6 of 7 national laboratories provided by T Lane, G de Jong, 
S Kavonic, W Pfaffenzeller, T Ruppelt). Since there were approximately 
830 000 deliveries in the government health sector of South Africa 
in 2007,5 and an estimated 17.2% of births are to women aged >35 
years,6 it is clear that only a tiny minority of AMA women receive 
prenatal diagnostic testing. Four of the 9 provinces of South Africa 
have no tertiary fetal medicine and medical genetic services.
The primary care facility audit gives possible reasons for low 
rates of genetic counselling for AMA in our service: late initiation 
of antenatal care and missed opportunities for prenatal counselling 
in AMA women attending early, both owing to patient- and staff-
related factors. The uncertainty among primary care staff regarding 
current guidelines for referral to genetic counselling suggests a need 
for clear communication of provincial policy documents to primary 
care level. Late initiation of antenatal care is common in South 
Africa; it is estimated7 that only 27% of South African women initiate 
antenatal care before 20 weeks’ gestation. South African studies have 
found several reasons for late initiation of antenatal care, including: 
(i) socio-economic factors e.g. related to transport costs, (ii) lack of 
knowledge of the importance of antenatal care, (iii) unwelcoming 
health services,8 (iv) lack of knowledge of the potential health threats 
in pregnancy,9 and (v) frequent missed opportunities for referral to 
genetic counselling from other primary care services – either clinics 
or private sector general practitioners.10 One or more of these factors 
are probably at work in our setting, and further study is warranted.
A dramatic reduction in the uptake of amniocentesis for AMA 
in CT West in the last 15 years is demonstrated. The reasons 
are uncertain, but several possibilities are outlined. Significant 
shifts have occurred in the demographic characteristics of women 
using public sector antenatal services: higher-income women now 
attend private sector antenatal care, which may be important since 
women of higher socio-economic status are more likely to accept 
amniocentesis.11 The democratic culture since 1994 has significantly 
increased public awareness of ‘patient rights’, which might have 
influenced reproductive choices. Public perceptions of disability 
might have changed for several reasons, including the introduction 
of a grant for the care of disabled children. There has been a dramatic 
increase in HIV among South African women, and untreated HIV-
infected South African women are less likely to want amniocentesis.12 
However, HIV is at most a partial explanation: the availability of 
antiretroviral prophylaxis has improved considerably in recent years; 
and in addition, the estimated 15.3% prevalence of HIV among 
pregnant women in the Western Cape13 appears insufficient to have 
had a major impact on overall amniocentesis rates.
Amniocentesis uptake for AMA is variable in other parts of South 
Africa: 29.9% in Johannesburg (T Wessels, unpublished data), and 
52.2% in Cape Town Metropole East district (G de Jong, unpublished 
data). Reasons for these differences have not been explored but 
may include differences in culture, access, counselling and referral 
patterns.
The reduction in amniocentesis for AMA has been offset by an 
increasing number of amniocenteses for fetal anomalies, resulting 
in a levelling off in overall numbers of amniocenteses performed. 
In part, these changes reflect an improvement in the availability and 
quality of prenatal ultrasound, with an emphasis mainly on the 20 - 
22-week fetal anomaly scan. It is uncertain whether this has affected 
referral patterns for AMA.
It is clear that many AMA women do not receive genetic counselling 
and many others decline prenatal testing, and that the strategy of 
AMA screening is inefficient compared with other prenatal screening 
methods. A local study found that an age cut-off of 37 years had 
Table I. Uptake of amniocentesis per indication, in Cape Town Metropole West – comparison of two time periods
1992-1994 (2-year period)* 2008-2009 (2-year period) p-value (Yates chi square)
Total 466 1 185
Amniocentesis uptake in all AMA women 191/258 (74.0%)† 158/507 (31.1%)‡ p<0.0001
OR 0.16 (CI 0.11 - 0.22)
Amniocentesis uptake in women >39 years 191/258 (74.0%) 123/360 (34.1%) p<0.0001
OR 0.18 (CI 0.13 - 0.26)
Fetal anomaly on ultrasound N=66 N=399
No. offered amniocentesis Not documented 172 two
Uptake of amniocentesis 17 118/172 (68.6% of those offered 
amnio)
Other 142 279
*Data extracted from Viljoen et al.4
†In this time period, the age cut-off for AMA was 39 years.
‡In this time period, the age cut-off for AMA was 37 years.
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a maximal detection rate of 43.3% and that lowering the cut-off 
to 35 years would only improve the detection rate to 52%, while 
significantly increasing the number of procedures performed.14
The way forward, we believe, is that prenatal screening and 
diagnosis should continue to be offered, but that alternatives to age-
based screening must be sought. A promising option would be to 
improve integration of DS screening with fetal ultrasound services. 
This would permit screening for DS in younger women as well, 
and could be integrated with screening for other fetal anomalies. 
An ultrasound-based approach achieved a prenatal detection rate 
for DS of 25.3%14 – approximately double our maximum estimated 
detection rate. While the utility of ultrasound for prenatal screening 
and diagnosis has been debated,15 ultrasound has additional benefits, 
including accurate pregnancy dating and early detection of unexpected 
problems.16,17 Fetal ultrasound also appears to be popular with parents 
and primary health care providers, which will probably improve the 
link between primary and tertiary care. Fetal ultrasound services are 
therefore increasingly used and, in metropolitan areas, fetal medicine 
is increasingly important. The service should be interdisciplinary, 
including fetal medicine specialists, ultrasonographers, medical 
geneticists and genetic counsellors, and should aim to provide 
an equitable service at all levels of care, and to women outside 
metropolitan areas.
Limitations. The study was limited by the retrospective nature 
of the data, although this factor applies particularly to the analysis 
of the cytogenetic laboratory database since it represents 30 years of 
historical data. The available data did not permit us to link prenatal 
and postnatal diagnoses of DS, and our approaches to improving the 
comparability of prenatal and postnatal diagnoses are discussed in 
the methods section. Unfortunately, no detailed annual provincial 
or national data exist regarding maternal age, which could be used 
to estimate the expected birth prevalence of DS, and would provide 
useful comparative information. For convenience, the audit of the 
primary health care facility focused on women delivering at the 
facility, and excluded women at high obstetric risk who would be 
transferred to other levels of care. Therefore the sample represents 
only AMA women of lower obstetric risk. These weaknesses are 
mitigated by the multiple data sources used and similar trends from 
various sources.
We thank Ms B Mentoor for collecting data at the primary health centre, 
and the staff of the primary health centre for their participation.
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